These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 10613023)

  • 21. Cost utility of drugs for multiple sclerosis. Methods used don't calculate true benefit.
    Richards R; Burls A; Payne N
    BMJ; 2000 May; 320(7247):1475; author reply 1475-6. PubMed ID: 10877570
    [No Abstract]   [Full Text] [Related]  

  • 22. Patient and family fact sheet. Current treatments for multiple sclerosis.
    Kernich CA
    Neurologist; 2005 Mar; 11(2):137-8. PubMed ID: 15733335
    [No Abstract]   [Full Text] [Related]  

  • 23. Betaseron: a breakthrough treatment for multiple sclerosis.
    Morrison W; Nelson J
    Can Nurse; 1996 Oct; 92(9):38-41. PubMed ID: 9118060
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Diagnostics and drug therapy of multiple sclerosis].
    Suomen Neurologinen Yhdistys ry
    Duodecim; 2002; 118(13):1411-23. PubMed ID: 12239889
    [No Abstract]   [Full Text] [Related]  

  • 25. [Drug therapy of multiple sclerosis].
    Kinnunen E
    Duodecim; 1999; 115(4):403-7. PubMed ID: 11830889
    [No Abstract]   [Full Text] [Related]  

  • 26. [10 years of interferon treatment in multiple sclerosis. Does the future belong to high-dose therapy?].
    MMW Fortschr Med; 2003 May; 145 Suppl 2():108. PubMed ID: 14579501
    [No Abstract]   [Full Text] [Related]  

  • 27. Can blood gene expression predict which patients with multiple sclerosis will respond to interferon?
    Kaminski N; Achiron A
    PLoS Med; 2005 Feb; 2(2):e33; quiz e51. PubMed ID: 15736992
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [A short history of beta-interferon therapy of multiple sclerosis].
    Stock G; Horowski R
    Med Klin (Munich); 2001 Sep; 96 Suppl 1():3-9. PubMed ID: 11603113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost utility of drugs for multiple sclerosis. Analysis goes too far.
    Ellis SJ
    BMJ; 2000 May; 320(7247):1475-6. PubMed ID: 10877571
    [No Abstract]   [Full Text] [Related]  

  • 30. ["The largest snapshot of multiple sclerosis". Interferons compared].
    MMW Fortschr Med; 2003 Jun; 145(24):55. PubMed ID: 12866307
    [No Abstract]   [Full Text] [Related]  

  • 31. Interferon causes no myasthenia in a seropositive patient with multiple sclerosis.
    Shimizu H; Kataoka H; Kawahara M; Hirano M; Furiya Y; Ueno S
    Clin Neurol Neurosurg; 2007 Apr; 109(3):277-8. PubMed ID: 17118531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Interferon beta in the treatment of multiple sclerosis--closing remarks.
    Kappos L
    Mult Scler; 1995; 1 Suppl 1():S64-6. PubMed ID: 9345403
    [No Abstract]   [Full Text] [Related]  

  • 33. Beta interferon, NICE, and rationing.
    Kernick D
    Br J Gen Pract; 2002 Sep; 52(482):784-5. PubMed ID: 12236297
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interferon beta-1b. New therapy for patients with secondary progressive multiple sclerosis].
    Nervenarzt; 1999 May; 70(5 Suppl):1-12. PubMed ID: 10368803
    [No Abstract]   [Full Text] [Related]  

  • 35. Chronic myeloid leukaemia in two multiple sclerosis patients on interferon beta-1a.
    Almeida L; Neves M; Cardoso E; Melo A
    J Clin Pharm Ther; 2009 Feb; 34(1):125-7. PubMed ID: 19125911
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interferon beta, PHARMAC, and political directives: in the best interests of people with multiple sclerosis?
    McNaughton H; Kayes N; McPherson K
    N Z Med J; 2006 Apr; 119(1232):U1939. PubMed ID: 16633398
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The treatment of multiple sclerosis with beta-interferon 1a].
    Rivera VM
    Rev Neurol; 2000 Sep 1-15; 31(5):470-1. PubMed ID: 11027100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ensuring the long-term effectiveness of MS treatment].
    Krankenpfl J; 2005; 43(7-10):235. PubMed ID: 16515305
    [No Abstract]   [Full Text] [Related]  

  • 39. [Current concepts on the use of some immunomodulatory drugs in the treatment of multiple sclerosis].
    Correale J; Cristiano E
    Medicina (B Aires); 2001; 61(4):470-80. PubMed ID: 11563177
    [TBL] [Abstract][Full Text] [Related]  

  • 40. NICE's appraisal procedures attacked.
    Kmietowicz Z
    BMJ; 2000 Oct; 321(7267):980. PubMed ID: 11039954
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.